These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 10516369

  • 1. National perspective on iron therapy as a clinical performance measure for maintenance hemodialysis patients.
    Owen WF, Szczech L, Johnson C, Frankenfield D.
    Am J Kidney Dis; 1999 Oct; 34(4 Suppl 2):S5-S11. PubMed ID: 10516369
    [Abstract] [Full Text] [Related]

  • 2. Anemia management of adult hemodialysis patients in the US results: from the 1997 ESRD Core Indicators Project.
    Frankenfield D, Johnson CA, Wish JB, Rocco MV, Madore F, Owen WF.
    Kidney Int; 2000 Feb; 57(2):578-89. PubMed ID: 10652035
    [Abstract] [Full Text] [Related]

  • 3. Current management of anemia in adult hemodialysis patients with end-stage renal disease.
    Frankenfield DL, Johnson CA.
    Am J Health Syst Pharm; 2002 Mar 01; 59(5):429-35. PubMed ID: 11887409
    [Abstract] [Full Text] [Related]

  • 4. Erythropoietin and iron use in peritoneal dialysis patients. Report from the 1997 HCFA end-stage renal disease core indicators project.
    Bailie GR, Frankenfield DL, Prowant BF, McClellan W, Rocco MV.
    Am J Kidney Dis; 1999 Jun 01; 33(6):1187-9. PubMed ID: 10352214
    [Abstract] [Full Text] [Related]

  • 5. Cost-effectiveness impact of iron dextran on hemodialysis patients' use of epoetin alfa and blood.
    Driver PS.
    Am J Health Syst Pharm; 1998 Dec 15; 55(24 Suppl 4):S12-6. PubMed ID: 9872688
    [Abstract] [Full Text] [Related]

  • 6. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
    Chen YC, Hung SC, Tarng DC.
    Am J Kidney Dis; 2006 Jun 15; 47(6):1036-44. PubMed ID: 16731299
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Diagnostic value of iron indices in hemodialysis patients receiving epoetin.
    Kaufman JS, Reda DJ, Fye CL, Goldfarb DS, Henderson WG, Kleinman JG, Vaamonde CA, Department of Veterans Affairs Cooperative Study Group on Erythropoietin in Hemodialysis Patients.
    Kidney Int; 2001 Jul 15; 60(1):300-8. PubMed ID: 11422765
    [Abstract] [Full Text] [Related]

  • 10. Maintaining higher TSATs and other iron indices is beneficial in management of anemic hemodialysis patients.
    Besarab A, Dalton CL.
    Nephrol Nurs J; 2001 Aug 15; 28(4):429-34. PubMed ID: 12143465
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The importance of iron in long-term survival of maintenance hemodialysis patients treated with epoetin-alfa and intravenous iron: analysis of 9.5 years of prospectively collected data.
    Pollak VE, Lorch JA, Shukla R, Satwah S.
    BMC Nephrol; 2009 Feb 26; 10():6. PubMed ID: 19245700
    [Abstract] [Full Text] [Related]

  • 13. Monitoring iron status in end-stage renal disease patients on hemodialysis.
    Rafi A, Karkar A, Abdelrahman M.
    Saudi J Kidney Dis Transpl; 2007 Mar 26; 18(1):73-8. PubMed ID: 17237895
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Should we limit the ferritin upper threshold to 500 ng/ml in CKD patients?
    Dukkipati R, Kalantar-Zadeh K.
    Nephrol News Issues; 2007 Jan 26; 21(1):34-8. PubMed ID: 17269263
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.